Evidence map›Paper›PMID 18981139›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.

Yoshikazu Naiki, Rosalinda Sorrentino, Michelle H Wong, Kathrin S Michelsen, Kenichi Shimada, Shuang Chen, Atilla Yilmaz, Anatoly Slepenkin, Nicolas W J Schröder, Timothy R Crother and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 100 citations in OpenAlex.

  1. Frequency and Relevance of MYD88European journal of neurology · 2025
    Article
  2. Article
  3. Article
  4. Frontiers in cell and developmental biology · 2022
    Article
  5. Article
  6. Article
  7. Infection and atherosclerosis: TLR-dependent pathways.Cellular and molecular life sciences : CMLS · 2020
    Review
  8. Article
  9. Article
  10. BioMed research international · 2018
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Manipulation of Host Cholesterol by Obligate Intracellular Bacteria.Frontiers in cellular and infection microbiology · 2017
    Review
  16. Article
  17. Forum on immunopathological diseases and therapeutics · 2016
    Article
  18. Review
  19. Infection and Atherosclerosis Development.Archives of medical research · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Yoshikazu NaikiDivision of Pediatric Infectious Diseases, Cedars-Sinai Medical Center and David Geffen School of Medicine, University of California, Los Angeles, CA 90048, USA.
Rosalinda Sorrentino
Michelle H Wong
Kathrin S Michelsen
Kenichi Shimada
Shuang Chen
Atilla Yilmaz
Anatoly Slepenkin
Nicolas W J Schröder
Timothy R Crother
Yonca Bulut
Terence M Doherty
Michelle Bradley
Zory Shaposhnik
Ellena M Peterson
Peter Tontonoz
Prediman K Shah
Moshe Arditi
University of California, Los Angeles · USCedars-Sinai Medical Center · USInstitute of Molecular Biology · BGUniversity of California, Irvine · USUniversitätsklinikum Erlangen · DE

Funding

ULTRASTRUCTURE OF THE INTIMA IN EARLY LESION FORMATIONP01HL030568 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FOGELMAN, ALAN M · 1985 to 2019
$55.2M
NUCLEAR RECEPTOR SIGNALING PATHWAYS IN ATHEROGENESISR01HL066088 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TONTONOZ, PETER J · 2001 to 2018
$5.4M
MOLECULAR PATHOGENESIS OF CHLAMYDIA-INDUCED ATHEROGENESIR01HL066436 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI ARDITI, MOSHE · 2001 to 2013
$3.6M
MD2 signaling in LPS/TLR4 induced cellular responsesR01AI058128 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI ARDITI, MOSHE · 2004 to 2009
$2.4M
Role of Innate Immunity in Pathogenesis of Chlamydia Pneumonia InfectionR01AI067995 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI ARDITI, MOSHE · 2006 to 2010
$1.9M
Howard Hughes Medical InstituteNHLBI NIH HHS 2P01HL030568NHLBI NIH HHS 5R01HL066088NHLBI NIH HHS P01 HL030568NHLBI NIH HHS R01 HL066088NHLBI NIH HHS R01 HL066436NHLBI NIH HHS R01HL66436NIAID NIH HHS 5R01AI058128NIAID NIH HHS 5R01AI067995NIAID NIH HHS R01 AI058128NIAID NIH HHS R01 AI067995
6 · The paper itself

Abstract

Experimental and clinical studies link Chlamydia pneumoniae infection to atherogenesis and atherothrombotic events, but the underlying mechanisms are unclear. We tested the hypothesis that C. pneumoniae-induced acceleration of atherosclerosis in apolipoprotein E (ApoE)(-/-) mice is reciprocally modulated by activation of TLR-mediated innate immune and liver X receptor alpha (LXRalpha) signaling pathways. We infected ApoE(-/-) mice and ApoE(-/-) mice that also lacked TLR2, TLR4, MyD88, or LXRalpha intranasally with C. pneumoniae followed by feeding of a high fat diet for 4 mo. Mock-infected littermates served as controls. Atherosclerosis was assessed in aortic sinuses and in en face preparation of whole aorta. The numbers of activated dendritic cells (DCs) within plaques and the serum levels of cholesterol and proinflammatory cytokines were also measured. C. pneumoniae infection markedly accelerated atherosclerosis in ApoE-deficient mice that was associated with increased numbers of activated DCs in aortic sinus plaques and higher circulating levels of MCP-1, IL-12p40, IL-6, and TNF-alpha. In contrast, C. pneumoniae infection had only a minimal effect on atherosclerosis, accumulation of activated DCs in the sinus plaques, or circulating cytokine increases in ApoE(-/-) mice that were also deficient in TLR2, TLR4, or MyD88. However, C. pneumoniae-induced acceleration of atherosclerosis in ApoE(-/-) mice was further enhanced in ApoE(-/-)LXRalpha(-/-) double knockout mice and was accompanied by higher serum levels of IL-6 and TNF-alpha. We conclude that C. pneumoniae infection accelerates atherosclerosis in hypercholesterolemic mice predominantly through a TLR/MyD88-dependent mechanism and that LXRalpha appears to reciprocally modulate and reduce the proatherogenic effects of C. pneumoniae infection.

Indexed as

AnimalsAortaApolipoproteins EAtherosclerosisChlamydia InfectionsChlamydophila pneumoniaeCytokinesDendritic CellsDNA-Binding ProteinsFluorescent Antibody TechniqueGene ExpressionGranulocyte-Macrophage Colony-Stimulating FactorHypercholesterolemiaImmunohistochemistryLiver X ReceptorsMiceApolipoproteins ECytokinesDNA-Binding ProteinsGranulocyte-Macrophage Colony-Stimulating FactorLiver X ReceptorsMyd88 protein, mouseMyeloid Differentiation Factor 88Nr1h3 protein, mouseOrphan Nuclear ReceptorsReceptors, Cytoplasmic and NuclearToll-Like Receptors

Identifiers

PMID18981139
PMCPMC2683843
OpenAlexW2153194491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.